MET and cancer: Of the 22 IBC patient samples analyzed, the majority (17/22, 77%) displayed expression of matriptase, c-Met, and E-cadherin in infiltrating cancer cells and in the cancer cells of peritumoral and dermal lymphatic emboli (Figure 1 and Supplementary Figure S1).